StockNews.com Upgrades West Pharmaceutical Services (NYSE:WST) to “Buy”
West Pharmaceutical Services (NYSE:WST – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Other analysts ...
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day
Shares of West Pharmaceutical Services Inc. WST rallied 1.28% to $343.91 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 5 ...
standard-journal1d
West to Host Fourth-Quarter and Full-Year 2024 Conference Call
West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and ...
West Pharmaceutical sets first-quarter dividend at $0.21/share
EXTON, Pa. - West Pharmaceutical Services, Inc. (NYSE:WST), a company specializing in solutions for injectable drug ...